PeptImmune

The top 10 biotech deal terminations of 2011
Fierce Biotech
Thu, 12/22/11 - 08:00 am
GSK
Targacept
Shire
Renovo
Merck
Addex
Diamyd Medical
JNJ
Janssen Pharmaceuticals
Novartis
PeptImmune
Solvay
Depomed
Eli Lilly
Amylin
Portola Pharmaceuticals
Paratek
Cephalon
ImmuPharma
The 2011 Biotech Graveyard
Fierce Biotech
Mon, 10/31/11 - 11:46 am
Advanced Life Sciences
Altair
Ambrilla
ARYx
PeptImmune
Phenomix
Tolerx
Transdel
Peptimmune, Novartis Sign $500M Deal for MS Drug
Bioworld
Sat, 01/17/09 - 09:12 am
PeptImmune
Novartis
MS
multiple sclerosis
Novartis gains option to license MS drug
Fierce Biotech
Fri, 01/16/09 - 09:56 am
PeptImmune
Novartis
MS
multiple sclerosis